Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
about
New approach to managing genital wartsHuman papillomavirus vaccination guideline update: American Cancer Society guideline endorsementEarly direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewAnnual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levelsModeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada.Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three yearsProspects for prevention of HPV-driven oropharynx cancer.Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program.Human papillomavirus vaccination: the population impact.Incremental benefits of male HPV vaccination: accounting for inequality in population uptake.Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical modelsDecreased management of genital warts in young women in Australian general practice post introduction of national HPV vaccination program: results from a nationally representative cross-sectional general practice study.Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.Anogenital Warts in Childhood - Always a Marker for Sexual Abuse?Reducing HPV-associated cancer globally.Tracking type specific prevalence of human papillomavirus in cervical pre-cancer: a novel sampling strategy.Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model.Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyEstimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in EuropeDecline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.HPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients.Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata.Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from AustraliaMeasuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?Human papillomavirus vaccination for boysKnowledge and perception of human papilloma virus vaccine among the antenatal women in a Nigerian tertiary hospitalQuantifying the decisional satisfaction to accept or reject the Human Papillomavirus (HPV) vaccine: a preference for cervical cancer preventionHigher prevalence of sexual transmitted diseases and correlates of genital warts among heterosexual males attending sexually transmitted infection clinics (MSCs) in Jiangmen, China: implication for the up-taking of STD related serviceSkin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancerHuman papillomavirus vaccination: current indications and future directionsGenital warts and cost of care in EnglandThe impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UKThe Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseA review of clinical trials of human papillomavirus prophylactic vaccines.Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study.Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.
P2860
Q27027521-FF3DD4BE-56A4-4F1A-AA2F-144A65A808FFQ28069669-7DD2DE35-89CC-4757-8A68-0DD7F09EABBDQ28081927-96F55961-4BCA-4FC9-B946-CCF5696FCA45Q30534669-9CA94E6F-893E-43B0-8316-9135F5404F48Q30573204-1A7DD891-66B3-4BA3-BC79-0330DA012405Q30764433-6EF4F8D6-A8F7-4550-8240-3AF4A374CCE5Q33756785-26FF99B4-9BCF-43DF-9518-6AF9EB692F5BQ33759930-91D5D9DE-611F-484C-9617-83545B087148Q33792465-A1E9EDDB-F07E-46E8-A178-07F560436A48Q33806566-A63B612A-6678-47D5-BD1E-0094C7B5D54CQ33999169-B23F6A67-848F-44D3-B608-016DA6CC33ABQ34113476-72096AE5-48B5-419D-85E4-AAB32F2FAA7AQ34122064-87B0716E-DE85-44EE-9D8D-1E2C33DB054DQ34133289-71744A0F-B8D5-40CB-8825-816004C70FA8Q34208841-55BDF813-C982-43E2-ACC3-C4BDE2D27D56Q34244580-04277E07-DDCE-4071-B9AE-8A724EA7C20BQ34304118-C60A25BF-073B-444A-A645-F858C76B3CB9Q34437088-1AEA6FEF-4BB8-4956-B74F-2164E5AD44F7Q34520216-963ABC5A-4DB6-484B-8800-EFDA1AC7CC90Q34539349-31955194-EF55-4A36-92D8-BFBCF3A08062Q34626578-BFBC6B67-C3BF-4765-8EE1-4C1F8074D2DAQ34636357-024EEC3E-EC01-4F2C-9051-F191CAE57806Q34698919-CD654DB6-33F0-4ACE-BD80-89F584220898Q34731097-39D21B17-71FA-42AE-9147-CE03F244E579Q34777452-F9C012B9-259E-4622-AC9C-9122F5897B88Q34806423-6D1CDF13-BAD4-4D32-9043-78A38E38FAD2Q34994792-63DDC688-2898-4988-9C9F-13C36E119987Q35041646-3ABE03E1-CE5E-46AB-8F5F-7DFB17DA9C62Q35097419-7CB9A964-E2D8-4409-8FA8-A7876282EC26Q35219566-233C87F4-4E7C-41B5-A7BE-7DD44D04FAE9Q35221196-8FB8D492-D72C-45DF-9771-736CDDDBD9CFQ35258843-4238279D-3A34-4C37-A767-625E30B32BFDQ35558593-C6D48BA9-DD5E-48E0-B400-3B46563C2BB0Q35658387-B08798E5-E292-4356-A91C-6A598D4CE2AAQ35658392-04DC5BC3-AD3A-4732-9BB8-9E37EF4F17A1Q35821324-914563BB-3F92-4DFE-8070-6E07E03BC49CQ36194955-E1541AB7-4F09-44DF-A362-20E0A0A82137Q36259403-15F87BBC-0650-4D62-8E74-FADB25CBC8A6Q36337242-52CAC741-AAAD-42AB-A59B-BB81F9CBC30FQ36529848-F16DCE88-F545-454F-AF57-5B01AD99ACA6
P2860
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@ast
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@en
type
label
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@ast
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@en
prefLabel
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@ast
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@en
P2093
P1476
Quadrivalent human papillomavi ...... al sentinel surveillance data.
@en
P2093
Andrew E Grulich
Basil Donovan
David G Regan
Hammad Ali
Handan Wand
Neil Franklin
Rebecca Guy
P356
10.1016/S1473-3099(10)70225-5
P577
2010-11-08T00:00:00Z